Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
1.260
+0.040 (3.28%)
At close: Jul 23, 2026, 4:00 PM EDT
1.290
+0.030 (2.38%)
Pre-market: Jul 24, 2026, 8:31 AM EDT
Daré Bioscience Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Current | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 23, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
| 19 | 26 | 28 | 29 | 22 | 26 | 27 | 28 | 34 | 49 | 31 | 45 | 79 | 90 | 70 | 85 | 104 | 125 | 168 | 128 | |
Market Cap Growth | -12.55% | 3.60% | 3.09% | 5.64% | -37.34% | -48.10% | -12.18% | -38.98% | -56.31% | -45.01% | -56.10% | -46.50% | -24.44% | -28.34% | -58.06% | -33.69% | -3.85% | 56.43% | 201.20% | 281.33% |
Enterprise Value | 7.54 | 9.59 | 5.93 | 9.11 | 19.58 | 18.82 | 12.75 | 17.86 | 19.55 | 47.3 | 21.84 | 31.68 | 65.8 | 70.19 | 36.22 | 45.02 | 73.41 | 86.97 | 116.48 | 82.74 |
Last Close Price | 1.26 | 1.82 | 1.93 | 2.10 | 2.39 | 2.89 | 3.12 | 3.24 | 4.03 | 5.88 | 3.71 | 5.54 | 10.92 | 12.48 | 9.96 | 12.00 | 14.76 | 17.88 | 24.00 | 20.04 |
PS Ratio | 16.31 | 22.90 | 27.16 | -512.02 | -1219.29 | 987.21 | 2774.45 | 14.72 | 12.13 | 17.49 | 11.01 | 45.38 | - | 8.96 | 7.04 | - | - | - | - | - |
PB Ratio | 25.00 | 36.11 | 9.84 | 10.24 | -1.69 | -2.67 | -4.52 | -18.65 | 12.89 | -4.48 | -6.12 | -19.83 | -28.99 | 18.03 | 6.34 | 3.22 | 3.16 | 4.05 | 4.33 | 4.01 |
P/TBV Ratio | 21.65 | 36.02 | 9.70 | 9.37 | - | - | - | - | 12.79 | - | - | - | - | 17.89 | 6.22 | 3.22 | 3.18 | 4.05 | 4.13 | 3.71 |
P/FCF Ratio | - | - | - | - | - | 4.20 | 5.54 | - | - | - | - | - | - | - | - | - | - | - | - | - |
P/OCF Ratio | - | - | - | - | - | 3.75 | 4.96 | - | - | - | - | - | - | - | - | - | - | - | - | - |
EV/Sales Ratio | 6.51 | 8.29 | 5.75 | -159.45 | -1106.17 | 726.40 | 1303.15 | 9.49 | 6.89 | 16.79 | 7.78 | 31.68 | - | 7.02 | 3.62 | - | - | - | - | - |
EV/FCF Ratio | - | - | - | - | - | 3.09 | 2.60 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Debt / Equity Ratio | 0.57 | 0.57 | 0.20 | 0.16 | -0.05 | -0.13 | -0.13 | -0.60 | 0.39 | -0.11 | -0.19 | 0 | -0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.03 | 0 | 0.00 |
Debt / EBITDA Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.95 | - | - | - |
Debt / FCF Ratio | - | - | 2.15 | - | - | - | 0.28 | - | 0.12 | - | - | - | - | - | - | 0.07 | - | - | - | 0.29 |
Net Debt / Equity Ratio | -23.04 | -23.04 | -7.76 | -7.05 | 0.16 | 0.71 | 2.39 | 6.62 | -5.57 | 0.18 | 1.80 | 5.99 | 4.79 | -3.91 | -3.08 | -1.51 | -0.94 | -1.23 | -1.33 | -1.42 |
Net Debt / EBITDA Ratio | 1.70 | 6.92 | 23.54 | 6.31 | 0.60 | 1.53 | 2.68 | 2.10 | 2.03 | 0.33 | 1.76 | 1.63 | 1.45 | 2.32 | 2.11 | 5.58 | -79.36 | 4.54 | 5.39 | 3.57 |
Net Debt / FCF Ratio | 1.66 | 3.06 | -17.82 | 32.66 | 0.38 | 1.20 | -3.03 | 1.74 | -1.18 | 0.29 | 1.03 | 1.71 | 1.98 | 1.21 | 5.79 | -4.66 | 3.66 | 3.09 | 5.18 | -34.60 |
Asset Turnover | 0.01 | 0.01 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.03 | 0 | 0 | 0 | 0 | 0.30 | 0 | 0 | 0 |
Quick Ratio | 0.91 | 0.91 | 1.04 | 1.11 | 0.27 | 0.49 | 0.73 | 0.89 | 1.19 | 0.28 | 0.56 | 0.57 | 0.56 | 0.91 | 1.15 | 1.87 | 2.67 | 2.50 | 3.29 | 2.87 |
Current Ratio | 1.03 | 1.03 | 1.14 | 1.18 | 0.34 | 0.56 | 0.85 | 1.14 | 1.43 | 0.56 | 0.86 | 0.85 | 0.90 | 1.21 | 1.36 | 2.17 | 3.03 | 2.92 | 3.44 | 3.03 |
Return on Equity (ROE) | 67.95% | 67.95% | 90.98% | -518.82% | 79.84% | 42.58% | 99.58% | 249.26% | -53911.20% | 224.14% | -166.79% | -69.00% | -57.81% | -44.87% | -63.94% | -24.11% | 2.03% | -49.21% | -50.75% | -83.06% |
Return on Assets (ROA) | -12.91% | -12.91% | -5.39% | -15.05% | -20.93% | -28.97% | -24.84% | -21.72% | -31.44% | -27.77% | -15.89% | -22.26% | -24.10% | -21.07% | -32.58% | -14.39% | 1.16% | -28.14% | -30.12% | -44.87% |
Return on Invested Capital (ROIC) | -36.39% | -36.39% | -25.13% | -62.02% | -63.47% | -72.62% | -128.15% | -145.58% | -326.84% | -256.76% | -191.77% | -418.71% | -413.38% | -587.36% | -1649.68% | -669.11% | 17.91% | -554.91% | -924.94% | -1059.91% |
Return on Capital Employed (ROCE) | -144.87% | -144.87% | -31.72% | -50.88% | -275.91% | 125.83% | -835.48% | -259.04% | -195.59% | -914.89% | -79.53% | -63.97% | -53.88% | -43.19% | -62.48% | -23.62% | 1.76% | -45.16% | -48.14% | -77.72% |
FCF Yield | - | - | - | - | - | 23.82% | 18.05% | - | - | - | - | - | - | - | - | - | - | - | - | - |
Buyback Yield / Dilution | -46.86% | -65.80% | -78.14% | -49.45% | -4.66% | -4.57% | -9.92% | -12.48% | -17.72% | -17.54% | -5.10% | -7.34% | -1.21% | -1.87% | -4.13% | -19.85% | -69.26% | -88.63% | -109.31% | -124.06% |
Total Shareholder Return | -46.86% | -65.80% | -78.14% | -49.45% | -4.66% | -4.57% | -9.92% | -12.48% | -17.72% | -17.54% | -5.10% | -7.34% | -1.21% | -1.87% | -4.13% | -19.85% | -69.26% | -88.63% | -109.31% | -124.06% |